Early Phase 1 Malaria Clinical Trials
7 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–7 of 7 trials
Not Yet Recruiting
Early Phase 1
A pilot study to examine the persistence and immunogenicity of Plasmodium falciparum 7G8 blood stage parasites following commencement of doxycycline chemoprophylaxis
Malaria
Griffith University3 enrolled1 locationACTRN12615001126505
Not Yet Recruiting
Early Phase 1
A pilot study in humans for purified Plasmodium falciparum 7G8 malaria parasites attenuated with Tafuramycin-A.
Malaria
Griffith University6 enrolled1 locationACTRN12615001085561
Completed
Early Phase 1
A safety and tolerability study in humans for chemically attenuated malaria parasites
Malaria
Griffith University9 enrolled1 locationACTRN12614000228684
Completed
Early Phase 1
Infectivity of the Plasmodium falciparum 7G8 malaria cell bank, MCB-004, in humans.
Malaria
Griffith University2 enrolled1 locationACTRN12613001187730
Withdrawn
Early Phase 1
A Safety and Tolerability Study in healthy adult males for Tafuramycin-A attenuated Plasmodium falciparum NF54 blood stage parasites.
Malaria
Griffith University6 enrolled1 locationACTRN12613000618752
Completed
Early Phase 1
Dose ranging study to examine the infectivity of the Plasmodium falciparum NF54 cell bank MCB-002 in healthy adult males
Malaria
Griffith University2 enrolled1 locationACTRN12613000615785
Completed
Early Phase 1
Infectivity of the Plasmodium falciparum NF54 malaria cell bank, MCB-002, in humans
Malaria
Griffith University2 enrolled1 locationACTRN12612001153808